In-silico analysis identifies marine compounds inhibiting NS1 from dengue virus, suggesting new treatments.
This study explores marine natural products as potential inhibitors of the non-structural protein 1 (NS1) from dengue virus type-2 (DENV-2). A comprehensive in-silico approach, including molecular docking and MMGBSA calculations, was employed to screen and evaluate marine-derived compounds for their binding affinity to the glycosylation site of NS1. Three novel compounds, CMNPD29267, CMNPD29280, and CMNPD29278, were identified as promising candidates, demonstrating strong binding affinities and binding-free energies. In silico ADMET analysis suggested these compounds possess favourable pharmacokinetic profiles with minimal predicted cardiotoxicity and central nervous system (CNS) toxicity.
No takes yet. Share an insight, caveat, or question.
Shaw et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: